SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has completed its previously announced acquisition of the Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing ...
Private investment company SK Capital has signed a new definitive agreement to purchase Perrigo Company’s active pharmaceutical ingredients (API) business, Perrigo API.Perrigo API develops and produces generic APIs and finished dose forms (FDF).
SK Capital has signed a definitive agreement to acquire Perrigo API business.This acquisition complements other companies SK owns and operates in the API and FDF value chain including Noramco, Tasmanian Alkaloids and Halo Pharmaceutical, all of which will